Skip to main content

Cognition Therapeutics Inc

CGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001455365

No open-market purchases or sales by Cognition Therapeutics Inc insiders were filed in the last 90 days; 66 institutions reported holding it in 13F filings for Q2 2026, worth $26.0M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Cognition Therapeutics Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
32
−1 vs. Q4 2022
Shares held
7.14M
+142.7K (+2.0%) vs. Q4 2022
Total value
$14.1M
+$4.09M (+40.7%) vs. Q4 2022
New holders
4
6 more added
Sold out
5
6 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 32 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 20 institutionsQ1 2022: 27 institutionsQ2 2022: 28 institutionsQ3 2022: 31 institutionsQ4 2022: 34 institutionsQ1 2023: 32 institutionsQ2 2023: 35 institutionsQ3 2023: 36 institutionsQ4 2023: 37 institutionsQ1 2024: 47 institutionsQ2 2024: 46 institutionsQ3 2024: 40 institutionsQ4 2024: 45 institutionsQ1 2025: 51 institutionsQ2 2025: 48 institutionsQ3 2025: 68 institutionsQ4 2025: 78 institutionsQ1 2026: 75 institutionsQ2 2026: 66 institutions
Value heldQ1 2023: $14.1M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $8.44MQ1 2022: $4.58MQ2 2022: $11.4MQ3 2022: $9.67MQ4 2022: $10.1MQ1 2023: $14.1MQ2 2023: $13.0MQ3 2023: $10.4MQ4 2023: $13.2MQ1 2024: $12.9MQ2 2024: $8.82MQ3 2024: $1.99MQ4 2024: $7.78MQ1 2025: $4.89MQ2 2025: $3.50MQ3 2025: $28.7MQ4 2025: $28.9MQ1 2026: $16.3MQ2 2026: $26.0M
Institutions holding CGTX and their total value by quarter
QuarterHoldersValue
Q2 202666$26.0M
Q1 202675$16.3M
Q4 202578$28.9M
Q3 202568$28.7M
Q2 202548$3.50M
Q1 202551$4.89M
Q4 202445$7.78M
Q3 202440$1.99M
Q2 202446$8.82M
Q1 202447$12.9M
Q4 202337$13.2M
Q3 202336$10.4M
Q2 202335$13.0M
Q1 202332$14.1M
Q4 202234$10.1M
Q3 202231$9.67M
Q2 202228$11.4M
Q1 202227$4.58M
Q4 202120$8.44M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Cognition Therapeutics Inc; share changes are against Q4 2022.

Institutions holding CGTX in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Pathstone Family Office, LLC2,210,377$4.38M0.07%00.0%Unchanged
AIGH Capital Management LLC2,037,853$4.03M1.49%00.0%Unchanged
Vanguard Group Inc643,390$1.27M0.00%+98,501+18.1%Added
Worth Venture Partners, LLC501,719$993.4K0.49%00.0%Unchanged
Carlson Capital L P245,169$485.4K0.05%+15,269+6.6%Added
Perigon Wealth Management, LLC225,000$445.5K0.03%−1,000−0.4%Reduced
American Financial Group Inc205,000$406.0K0.13%00.0%Unchanged
Commonwealth Equity Services, LLC168,692$334.0K0.00%−20,615−10.9%Reduced
Voss Capital, LLC159,973$316.7K0.04%−6,930−4.2%Reduced
Geode Capital Management, LLC122,598$242.7K0.00%00.0%Unchanged
Kestra Advisory Services, LLC95,000$188.1K0.00%+44,382+87.7%Added
Bridgeway Capital Management, LLC66,200$131.1K0.00%00.0%Unchanged
Fca Corp51,471$101.9K0.04%+51,471New
Rock Creek Group, LP50,000$99.0K0.01%00.0%Unchanged
Castle Wealth Management LLC43,380$85.9K0.07%00.0%Unchanged
BlackRock Inc.37,739$74.7K0.00%+1,122+3.1%Added
Neumann Capital Management, LLC33,382$66.1K0.03%00.0%Unchanged
State Street Corp30,250$59.9K0.00%00.0%Unchanged
HighTower Advisors, LLC28,561$58.0K0.00%+28,561New
Northern Trust Corp29,184$57.8K0.00%00.0%Unchanged
Two Sigma Investments, LP28,236$55.9K0.00%−18,384−39.4%Reduced
Northeast Financial Consultants Inc24,500$48.5K0.00%00.0%Unchanged
Baird Financial Group, Inc.22,393$44.3K0.00%+2,300+11.4%Added
Morgan Stanley21,869$43.3K0.00%00.0%Unchanged
Bangor Savings Bank19,019$37.7K0.00%00.0%Unchanged
Neuberger Berman Group LLC15,884$31.4K0.00%+15,884New
Diligent Investors, LLC10,000$19.8K0.01%−10,000−50.0%Reduced
Northwestern Mutual Wealth Management Co5,867$11.6K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)5,325$11.0K0.00%+1,131+27.0%Added
Bray Capital Advisors2,250$4.46K0.00%00.0%Unchanged
Wells Fargo & Company124$2460.00%−38,386−99.7%Reduced
FMR LLC1$20.00%+1New
Wealth Alliance Advisory Group, LLC0$00.00%−13,874−100.0%Sold out
UBS Group AG0$00.00%−5,543−100.0%Sold out
Royal Bank of Canada0$00.00%−400−100.0%Sold out
Bank of America Corp0$00.00%−46−100.0%Sold out
IFP Advisors, Inc0$00.00%−750−100.0%Sold out
Financial Partners Capital Management LLC––––Not filed